Over 300 species — some harmless, some deadly. Learn to tell the difference and protect your family.
Aspergillus is one of the most widespread fungal genera on Earth. With more than 300 described species, it is found in virtually every environment — in soil, decomposing plant matter, compost, food, and the indoor air of nearly every building. Discovered by Italian priest and botanist Pier Antonio Micheli in 1729 and named for the aspergillum (a liturgical water sprinkler), the genus takes its name from the brush-like appearance of its spore-bearing structures.
The vast majority of Aspergillus species are entirely harmless to healthy humans — they play vital ecological roles in nutrient cycling and are industrially important in the production of soy sauce, sake, citric acid, and pharmaceutical enzymes. A handful of species, however, are significant human pathogens, producing life-threatening infections in immunocompromised individuals and a spectrum of respiratory disease in healthy people with heavy exposure.
Aspergillus fumigatus is estimated to cause approximately 200,000 life-threatening invasive infections worldwide each year, with mortality rates of 30–95% in high-risk patient groups.
In buildings, Aspergillus is a frequent colonizer of damp materials and HVAC systems. It grows most aggressively where water activity is moderate (above 0.80 Aw) and cellulose-based substrates — drywall, ceiling tiles, wood framing, and insulation — are present. Understanding which species you are dealing with is clinically important because treatment, remediation urgency, and health risk differ substantially between, say, A. niger on shower grout and A. fumigatus in an HVAC duct.
Aspergillus is visually distinct from most other common molds under microscopy, though colony color varies enormously across species. The defining morphological feature is the conidial head — the spore-bearing structure that gives the genus its characteristic appearance. This structure consists of:
The overall structure resembles a watering can, aspergillum, or — as it appears under a microscope — a radiate fan or sunburst head. This morphology is unique to Aspergillus and allows trained laboratory technicians to identify the genus definitively on direct microscopy. Colony colors on standard culture media range from white (early growth) to yellow-green (A. flavus), blue-green to gray-green (A. fumigatus), black (A. niger), brown-cinnamon (A. terreus), and grayish-green to olive (A. versicolor).
Naked-eye identification of Aspergillus species is unreliable. Two households can have visually identical dark mold on drywall — one being relatively benign A. niger, the other being carcinogen-producing A. versicolor. Always request speciated laboratory identification.
Of the 300+ described species, five dominate clinical and indoor air quality literature. Their distinct characteristics — growth temperature, toxin production, and disease associations — are summarized in the comparison table below.
| Species | Colony Color | Temperature Range | Key Toxins | Primary Clinical Concern | ERMI Group |
|---|---|---|---|---|---|
| A. fumigatus | Blue-green to gray | 12–57°C (survives 50°C+) | Gliotoxin, fumagillin | Invasive aspergillosis; ABPA | Group 1 |
| A. flavus | Yellow-green | 10–48°C | Aflatoxin B1 (most potent known natural carcinogen) | Sinusitis; corneal infection; aflatoxicosis | Group 1 |
| A. niger | Black spore mass; white reverse | 6–47°C | Ochratoxin A (some strains) | Otomycosis; pulmonary aspergilloma | Group 2 |
| A. terreus | Cinnamon-brown | 20–48°C | Citrinin, patulin | Invasive aspergillosis (amphotericin-B resistant) | Group 1 |
| A. versicolor | Olive to gray-green | 4–37°C | Sterigmatocystin (aflatoxin precursor) | Chronic hypersensitivity; sick building syndrome | Group 1 |
The spectrum of human disease caused by Aspergillus — collectively termed aspergillosis — ranges from mild allergic reactions in healthy individuals to rapidly fatal infections in immunocompromised patients. The form of disease depends primarily on the host's immune status, the infecting species, and the magnitude of exposure.
ABPA is a complex hypersensitivity disorder in which the immune system mounts an exaggerated IgE- and IgG-mediated response to Aspergillus antigens colonizing the airways. It occurs almost exclusively in patients with chronic asthma or cystic fibrosis, affecting an estimated 1–15% of asthma patients and 2–15% of CF patients. Clinically, ABPA presents with wheezing, recurrent pulmonary infiltrates, bronchiectasis, and if untreated, progressive pulmonary fibrosis.
Diagnosis rests on elevated total serum IgE (>1,000 IU/mL), Aspergillus-specific IgE and IgG, peripheral blood eosinophilia, and characteristic CT chest findings. Treatment involves systemic corticosteroids to suppress immune-mediated lung damage, often combined with long-term antifungal therapy (itraconazole or voriconazole).
Untreated ABPA leads to permanent central bronchiectasis and fibrotic lung destruction. Early diagnosis and antifungal therapy can halt progression — but repair of established fibrosis is not possible.
Invasive aspergillosis represents the most feared form of the disease. It occurs when Aspergillus hyphae invade lung tissue and disseminate hematogenously to the brain, kidneys, heart, and other organs. It is almost exclusively a disease of profoundly immunocompromised patients: those undergoing allogeneic hematopoietic stem cell transplantation, solid organ transplantation, patients on high-dose corticosteroids, those receiving cytotoxic chemotherapy for hematologic malignancies, and patients with chronic granulomatous disease or late-stage HIV.
Voriconazole is the primary treatment, with isavuconazole as an alternative. Without antifungal treatment, mortality approaches 100%. Even with aggressive treatment, mortality in hematologic malignancy patients exceeds 40–50%. A. terreus is intrinsically resistant to amphotericin B — a critical point distinguishing it from other species — and is associated with particularly poor outcomes.
An aspergilloma is a mass of tangled Aspergillus hyphae, fibrin, mucus, and cellular debris that forms within a pre-existing pulmonary cavity — most commonly a cavity left by prior tuberculosis, sarcoidosis, or emphysematous bullae. The fungus colonizes the cavity without invading surrounding tissue, typically in patients with normal or mildly impaired immunity. Most aspergillomas are asymptomatic and discovered incidentally on chest imaging. The serious complication is hemoptysis (coughing up blood), which can be life-threatening and may require bronchial artery embolization or surgical resection.
Also called extrinsic allergic alveolitis, hypersensitivity pneumonitis from Aspergillus exposure is an immune-mediated interstitial lung disease triggered by repeated inhalation of large quantities of spores — typically in occupational settings (farming, composting, mushroom cultivation) or in homes with severe water damage and extensive mold growth. HP can be acute, subacute, or chronic, and repeated exposure without removal of the antigen source leads to permanent restrictive lung disease.
| Condition | Immune Status Required | Primary Species | Mortality Without Treatment | First-Line Treatment |
|---|---|---|---|---|
| Allergic rhinitis / asthma trigger | Normal (atopic) | A. fumigatus, A. flavus | Very low — not acutely fatal | Allergen avoidance, antihistamines |
| ABPA | Asthmatic or CF patient | A. fumigatus | Low (progressive fibrosis if untreated) | Systemic corticosteroids + itraconazole |
| Aspergilloma | Structurally abnormal lung | A. fumigatus, A. niger | Low (fatal hemoptysis possible) | Watchful waiting; surgery for hemoptysis |
| Hypersensitivity pneumonitis | Normal (heavy exposure) | A. fumigatus, A. flavus | Moderate if chronic and untreated | Antigen avoidance; corticosteroids |
| Chronic pulmonary aspergillosis | Mild immune compromise | A. fumigatus | Moderate (5-year mortality ~50%) | Long-term voriconazole or itraconazole |
| Invasive aspergillosis | Severely immunocompromised | A. fumigatus, A. terreus | Near 100% without treatment | Voriconazole (isavuconazole for A. terreus) |
Aspergillus flavus and closely related A. parasiticus are the primary producers of aflatoxins — a family of polyketide-derived secondary metabolites. Of the four major aflatoxin types (B1, B2, G1, G2), aflatoxin B1 (AFB1) is the most potent known naturally occurring carcinogen classified by the International Agency for Research on Cancer (IARC) as a Group 1 carcinogen — meaning the evidence for its carcinogenicity in humans is definitive.
Aflatoxin B1 is classified as IARC Group 1 — definitively carcinogenic to humans. It is the most potent naturally occurring hepatocarcinogen known; even low-level chronic dietary exposure significantly increases hepatocellular carcinoma risk, and this risk is synergistically amplified in people with hepatitis B infection.
AFB1 is primarily a food safety concern — it contaminates corn, peanuts, cottonseed, tree nuts, and spices when moisture levels during growth or storage allow A. flavus to proliferate. In the context of building mold, A. flavus can colonize damp cellulose materials and produce aflatoxins, but airborne inhalation doses in residential settings are generally orders of magnitude lower than dietary exposure routes.
Nonetheless, the presence of A. flavus in an occupied building is taken seriously by industrial hygienists because:
Standard mold inspections using air samples or surface swabs do not test for aflatoxin presence — only for fungal colony counts and spore identification. If A. flavus is identified in a building, mycotoxin surface testing using LC-MS/MS analysis can determine whether aflatoxin production has occurred on colonized materials.
Aspergillus niger, commonly called black aspergillus, is the most frequently encountered Aspergillus species in both indoor and outdoor environments. Its dense black spore masses make it visually striking and frequently misidentified as Stachybotrys chartarum (toxic black mold) by homeowners and even some contractors without laboratory confirmation.
In buildings, A. niger is commonly found on shower walls, tile grout, and silicone caulk; window sills and frames where condensation accumulates; insulation materials with moderate moisture exposure; refrigerator door gaskets and drip pans; paper-faced gypsum wallboard in areas of elevated humidity; and stored grains, fruits, and vegetables in pantry areas.
While A. niger is significantly less virulent than A. fumigatus, it should not be dismissed. It is the leading cause of otomycosis (fungal outer ear infection) and can cause pulmonary aspergilloma in susceptible patients. Some strains produce ochratoxin A — a nephrotoxic mycotoxin classified as IARC Group 2B (possible human carcinogen) that accumulates primarily in the kidneys with long-term exposure.
A. niger is NOT the same as Stachybotrys chartarum. While both appear dark or black on surfaces, they are completely different fungi with different toxin profiles, growth requirements, and remediation needs. Proper laboratory identification is essential before designing any remediation plan.
The term "black mold" is frequently applied to any dark-colored mold growth in homes, leading to significant confusion between A. niger and Stachybotrys chartarum. These are biologically, toxicologically, and ecologically very different organisms with different remediation requirements.
| Characteristic | Aspergillus niger | Stachybotrys chartarum |
|---|---|---|
| Visual appearance | Black spore mass; white colony underside | Dark greenish-black; slimy when wet |
| Growth speed | Fast (2–3 days to visible colonies) | Slow (several weeks to visible growth) |
| Minimum moisture (Aw) | 0.77 Aw | 0.94 Aw — requires chronic saturation |
| Preferred substrate | Varied — tile, caulk, paper, food, soil | Cellulose-rich only: drywall paper, wood, cardboard |
| Primary toxins | Ochratoxin A (some strains) | Trichothecene mycotoxins (satratoxins) |
| Spore release mechanism | Dry conidia, easily aerosolized passively | Wet, sticky spores — low release unless physically disturbed |
| ERMI classification | Group 2 (common background mold) | Group 1 (significant moisture damage indicator) |
| Clinical risk in healthy adults | Primarily allergic; otomycosis | Debated; primarily concerns immunocompromised |
The practical implication: finding A. niger on bathroom tile is a different situation from finding Stachybotrys behind drywall. The former suggests surface moisture; the latter indicates prolonged structural water intrusion and potential trichothecene contamination of building materials. Both require professional evaluation, but remediation scope and urgency differ significantly.
The Environmental Relative Moldiness Index (ERMI) was developed by the U.S. EPA to assess mold contamination in homes using dust sampling and quantitative PCR (QPCR). ERMI classifies 36 mold species into two groups: Group 1 (26 water-damage-indicator species) and Group 2 (10 common background species found in most buildings regardless of moisture history).
Several Aspergillus species fall in ERMI Group 1, including A. fumigatus, A. flavus, A. terreus, and A. versicolor. Their presence in dust samples at elevated levels is therefore considered a marker of moisture problems — not simply background environmental contamination. A. niger is classified as ERMI Group 2, meaning its presence alone is less diagnostically meaningful unless counts are unusually high.
An ERMI score above +5 is associated with a significantly increased risk of asthma development in children and respiratory symptoms in adults. Multiple Group 1 Aspergillus species in a single dust sample is a strong indicator of water-damage-related colonization requiring professional investigation.
It is important to note that ERMI is a research tool originally developed for epidemiological studies, not as a clinical diagnostic test. The American Industrial Hygiene Association (AIHA) recommends interpreting ERMI results in the context of a full visual inspection, moisture measurements, and air sampling — not as a standalone pass/fail metric.
Aspergillus fumigatus is the single most clinically important species in the genus, and its extraordinary thermotolerance is a primary reason for this distinction. While most environmental molds are inhibited or killed at temperatures above 40°C, A. fumigatus thrives at human body temperature (37°C) and can survive and even grow at temperatures exceeding 50°C — a thermal tolerance matched by very few other fungi.
This thermal resilience has several important implications for building occupants and healthcare facilities:
In the built environment, Aspergillus species colonize a wide range of materials. Understanding which materials are highest risk helps focus both inspection and remediation efforts.
When a mold inspector collects air samples, Aspergillus and Penicillium are typically reported together as "Asp/Pen" because their conidia are morphologically indistinguishable by standard optical microscopy. This combined category is one of the most common findings in both outdoor and indoor air samples and requires careful interpretation to avoid both over- and under-reaction.
A common mistake: declaring a building "safe" because total mold spore counts are low on air samples. Even low counts of A. fumigatus carry significant risk for neutropenic patients. Any detectable A. fumigatus in a building occupied by transplant or chemotherapy patients requires immediate professional investigation.
Remediation of Aspergillus contamination in buildings follows IICRC S520 Standard for Professional Mold Remediation principles, with additional precautions specific to this genus's thermotolerance, spore characteristics, and potential mycotoxin production on colonized materials.
Before containment is dismantled and areas are reopened, post-remediation clearance testing must confirm that spore counts have returned to expected background levels. Clearance testing should include both air samples and surface tape-lift or swab samples, with comparison to outdoor control samples taken simultaneously. For buildings with immunocompromised occupants, QPCR-based testing for A. fumigatus specifically is recommended in addition to standard microscopy-based air sampling.
Most healthy adults inhale hundreds of Aspergillus spores every day without any health consequences — the immune system efficiently clears them via alveolar macrophages. The significant risk population is immunocompromised individuals: transplant recipients, chemotherapy patients, those on long-term high-dose corticosteroids, and people with advanced HIV. For healthy adults, the primary concerns are allergic reactions, ABPA in asthmatics and CF patients, and occupational exposure to massive spore counts (farming, composting).
Visually and by spore morphology under standard light microscopy, Aspergillus and Penicillium conidia appear nearly identical — both are roughly round, 2–5 µm, and pale green to olive in color. Definitive differentiation requires either culture evaluation (colony morphology and conidial head examination at 7–10 days on specialized media) or molecular identification using ITS region PCR sequencing. ERMI dust testing via QPCR specifically detects and distinguishes each Aspergillus species by unique genetic markers.
Yes. HVAC systems — particularly cooling coils, condensate drain pans, and flexible duct liner — are prime colonization sites for A. fumigatus and A. versicolor. Contaminated HVAC systems distribute spores to all rooms served by the ductwork. Annual HVAC coil cleaning, maintaining proper condensate drainage, and replacing contaminated duct liner are essential for prevention. If Aspergillus is detected in HVAC, an IICRC-certified HVAC remediation contractor should perform full decontamination — simply replacing the filter is not sufficient.
Aspergillus species produce various volatile organic compounds (VOCs) during growth, contributing to what is commonly described as a musty, earthy, or slightly sweet odor. A. fumigatus specifically produces compounds including trans-2-octenal and 1-octen-3-ol. However, odor alone is not a reliable indicator — the absence of a detectable odor does not rule out Aspergillus colonization, and many other molds produce identical odor profiles. Professional air and surface sampling remains the only reliable identification method.
No — they are completely different fungi. Aspergillus versicolor produces sterigmatocystin, a structural precursor to aflatoxins and itself a possible carcinogen (IARC Group 2B). It is a Group 1 ERMI mold associated with water-damaged buildings and is commonly found in wall cavities and HVAC systems. Unlike Stachybotrys, A. versicolor produces dry airborne conidia that are easily inhaled during routine building activities. It requires IICRC-standard remediation with proper HEPA containment and occupant protection.
Small-scale Aspergillus remediation — such as contaminated bathroom caulk or a small section of drywall — typically takes 1–3 days including setup, removal, treatment, and clearance testing. Larger-scale remediation involving HVAC systems, multiple rooms, or structural materials can take 1–3 weeks. Post-remediation clearance testing results, which determine when a space can be safely reoccupied, typically take 24–72 hours from a certified laboratory to process and report.